Generating novel crystal polymorphs of therapeutic compounds with uniform size distribution for improved solubility, hygroscopicity and manufacturability

Two pharmaceutical products for the treatment of neurological diseases developed by Neuractas Therapeutics require fine tuning to enhance their solubility, bioavailability and stability towards relative humidity. Extensive experimental research will be carried out to improve the polymorphic distribution of the products by high through-put crystallization to improve the solubility of one of the products. In […]

Read More